Overview

Bioburden Testing Market is poised to register a CAGR of 12.4% during the forecast period 2022 to 2028.

Bioburden testing is the study of the microbial count present on the surface of any material or product. The term is used for testing the contamination in pharmaceutical products, food and beverages, medical devices, etc. Bioburden testing is mandatory as per ICH (International Conference on Harmonization) guidelines for the manufacturing and distribution of food and drugs along with medical devices.

For an FDA ( Food and Drug Administration) approval the bioburden testing as per ICH guidelines must be followed. This is the key factor driving the bioburden testing market.

Growth in the pharmaceutical products, food and beverages, medical devices across the globe are factors contributing to bioburden market growth and are positively influencing the CAGR. The risk of microbial contamination in healthcare products and hence the related safety concerns can not be ignored. It is the key factor driving the market.

The consumables like culture media and reagents are estimated to contribute as a major part of the market growth across the globe. Culture media and reagents are basic ingredients used for bioburden testing. Any negligence in the safety and sterility conditions of the product creates severe health problems and a huge loss in the market. To avoid such consequences, bioburden testing is the key.

The contamination in raw materials is detected by anaerobic count testing. The safety and economic concerns related to raw materials have driven the preference for anaerobic count testing in the market. The rising demand for anaerobic count testing is one of the key elements driving its contribution to the market.

Pharmaceutical and biotechnology companies contribute to the large share of the bioburden testing market worldwide. Pharma companies involve bioburden testing at every step of manufacturing starting from raw materials to finished products. This is the major feature that drives the growth of the market.

North America is estimated to hold a large share in the market. The rise in research and development activities and massive investments in these activities play a major role in market growth. The increasing scope for pharma industries in Asia Pacific s one of the dominating factors responsible for the market to grow.

Major Market Players are:

Charles River, Merck KGaA, SGS SA, Wuxi Apptec, BD, North American Science Associates Inc. (NAMSA), Nelson Laboratories, LLC, Thermo Fisher Scientific, Biomérieux SA, Pacific Biolabs.

Bioburden Testing Market Segmentation:

By Product

• Consumables
o Culture Media, Reagents, and Kits
o Other Consumables
• Instruments
o Automated Microbial Identification Systems
o Pcr Instruments
o Microscopes
o Other Instruments

By Test Type

Aerobic count testing
Anaerobic count testing
Fungi/ Mold count testing
Spore count testing

By Application

Raw material testing
Medical device testing
In-process material testing
Sterilization validation testing
Equipment cleaning validation

By End User

Pharmaceutical and biotechnology companies
Medical device manufacturers
Contract manufacturing organizations
Manufacturers of Food & Beverage and Agricultural Products
Microbial Testing Laboratories

By Region

North America
Europe
Asia Pacific
Rest of the world

Competitive Landscape:

Tier 1 players- established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants

FutureWise Key Takeaways:

New advancements in bioburden testing methods
Investment in bioburden consumables products
Collaboration bioburden testing organization

Objectives of the Study:

To provide with an exhaustive analysis on the bioburden testing market by product, by test type, by application, by end user and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, and the rest of the world
To record evaluate and competitive landscape mapping-product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com